# Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders

- **DOI:** [10.1002/14651858.cd010734.pub2](https://doi.org/10.1002/14651858.cd010734.pub2)
- **Rating:** Strong (4.2 out of 5)
- **Verdict:** A systematic synthesis supports increased urinary iodine from non-salt fortification, but sparse clinical evidence limits its value for implementation decisions.
- **Framework version:** v5.10
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-11-08
- **Evaluation page:** https://www.nabu.science/paper/10.1002%2F14651858.cd010734.pub2

## Key claims

1. Pooled results from RCTs showed that urinary iodine concentration significantly increased following iodine fortification (SMD 0.59, 95% CI 0.37 to 0.81; 6 RCTs, 2032 participants; moderate-quality evidence).
   - Support: Supported
   - Type: Primary finding
   - Basis: design-stratified trial synthesis supports the biomarker increase despite substantial heterogeneity and high-risk studies
   - Location: Abstract, Main results; Results, Urinary iodine concentration; Figure 6
2. The evidence on the effect of iodine fortification of foods, beverages, condiments, or seasonings other than salt on reducing goitre, improving physical development measures, and any adverse effects is uncertain.
   - Support: Tentative
   - Type: Secondary
   - Basis: clinical estimates rely principally on one small non-randomised study, with safety assessed only in a small crossover trial
   - Location: Abstract, Authors' conclusions
3. One study reported that there were no adverse events observed during the cross-over trial (low-quality evidence).
   - Support: Tentative
   - Type: Secondary
   - Basis: a small, short infant nutrient-balance trial provides indirect and imprecise safety evidence
   - Location: Abstract, Main results

## Strengths

- **Broad searches support a reproducible synthesis** The search covers international and regional databases, grey literature, theses, trial registries and organisational contacts without language restrictions. Appendix 1 supplies the search strategies.
  - Dimension: methodological rigour
  - Location: Methods, Search methods; Appendix 1
- **Distinct evidence map for alternative vehicles** The review synthesises non-salt iodine-fortification studies separately from established salt and supplementation evidence. It distinguishes an observed biomarker increase from unresolved clinical benefits.
  - Dimension: contribution
  - Location: Background, Why it is important to do this review; Summary of findings
- **Limitations shape interpretation and practice conclusions** The discussion connects absent clinical outcomes, restricted populations and unexplained heterogeneity to limits on inference. The practice conclusions explicitly request more efficacy and safety evidence before widespread implementation.
  - Dimension: positioning
  - Location: Discussion, Overall completeness and applicability; Authors' conclusions, Implications for practice

## Limitations

- **Unresolved heterogeneity complicates the certainty rating** The primary RCT urinary-iodine analysis has I² = 81%, yet its moderate-certainty rating is downgraded only for risk of bias. Post-hoc subgroup analyses do not fully explain the variability.
  - Dimension: methodological rigour
  - Location: Figure 6; Summary of findings, footnote 10; Discussion, Summary of main results
- **Clinical and safety evidence remains sparse** The main positive result concerns urinary iodine rather than prevention of clinically important disorders. Goitre and growth evidence is very uncertain, and adverse-event evidence comes from one small crossover trial.
  - Dimension: contribution
  - Location: Abstract, Main results; Summary of findings
- **Robustness wording obscures changing effect estimates** Sensitivity analyses are described as not changing the effect, although the RCT estimate moves from SMD 0.59 to 0.73 and the non-RCT estimate from 0.25 to 0.00. The broad statistical conclusions persist, but the wording understates numerical variation.
  - Dimension: reporting
  - Location: Abstract, Main results; Results, Sensitivity analysis; Analyses 3.1 and 3.2

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted. One reported value does not reconcile, but the key claims do not rest on it.
  - Minor reporting notes (1):
    - Descriptive: "Biebinger 2009 | 213 | 214.75 | 44 | 138 | 115.25 | 43 | 12.3% | 0.43 [0.08, 0.86]" (Figure 6, row Biebinger 2009) vs "percent with iodine deficiency at baseline was unknown (SMD 0.43, 95% CI 0.00 to 0.86; 1 trial, 87 participants)" (Results, Subgroup analysis). The figure and subgroup text give lower bounds of 0.08 and 0.00 respectively, while approximate reconstruction from rounded means, SDs and sample sizes gives about 0.01. → Conclusion holds
- **Reporting and transparency:** Clean. A published protocol, protocol deviations, funding and competing interests are disclosed. No verified reporting or transparency finding is retained.
  - Conflict of interest: declared · Preregistration: declared
- **Reference integrity:** Noted
  - 114 references in manuscript
  - 82 of 87 checkable references found in an index
  - 26 are books, websites or datasets — counted, but not index-checkable
  - 1 could not be checked — not the same as no match found
  - Could not be verified automatically — queued for manual review:
    - Azizi F. Evaluation of the effects of iodine fortified-milk on lactating mothers' and their infants' iodine nutrition status. Iranian Registry of Clinical Trials (IRCT201305074794N9) 2013-05-20. (Ambiguous: title ratio 0.57 via crossref_bibliographic sits between the divergence (0.30) and match (0.70) thresholds; too close to call either way, so it is recorded as unresolved rather than judged.)
    - Todd CH. Hyperthyroidism and Other Thyroid Disorders: A Practical Handbook for Recognition and Management. Geneva: World Health Organization, 1999. (Ambiguous: title ratio 0.55 via crossref_bibliographic sits between the divergence (0.30) and match (0.70) thresholds; too close to call either way, so it is recorded as unresolved rather than judged.)
    - World Health Organization and Food and Agriculture Organization. Guidelines on Food Fortification with Micronutrients. Gevena, Switzerland: World Health Organization, 2006. (Crossref bibliographic top candidate ratio 0.38 — no plausible match)
    - WHO, UNICEF, ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring their Elimination. 3rd Edition. Geneva, Switzerland: World Health Organization, 2007. (Crossref bibliographic top candidate ratio 0.43 — no plausible match)
    - Allen L, de Benoist B, Dary O, Hurrell R, editor(s), World Health Organization, Food, Agriculture Organization of the United Nations. Guidelines on Food Fortification with Micronutrients. Geneva, Switzerland: World Health Organization, 2006. (Crossref bibliographic top candidate ratio 0.38 — no plausible match)
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-11-08
